|
1
|
Bayne CE, Williams SB, Cooperberg MR,
Gleave ME, Graefen M, Montorsi F, Novara G, Smaldone MC,
Sooriakumaran P, Wiklund PN, et al: Treatment of the primary tumor
in metastatic prostate cancer: Current concepts and future
perspectives. Eur Urol. May 20–2015.Epub ahead of print.
S0302–2838. (15): 00378-4. PubMed/NCBI
|
|
2
|
Miyake H and Fujisawa M: Prognostic
prediction following radical prostatectomy for prostate cancer
using conventional as well as molecular biological approaches. Int
J Urol. 20:301–311. 2013. View Article : Google Scholar
|
|
3
|
Lei JH, Liu LR, Wei Q, Song TR, Yang L,
Meng Y and Han P: Androgen-deprivation therapy alone versus
combined with radiation therapy or chemotherapy for nonlocalized
prostate cancer: A systematic review and meta-analysis. Asian J
Androl. 18:102–107. 2016. View Article : Google Scholar :
|
|
4
|
Nandana S and Chung LW: Prostate cancer
progression and metastasis: Potential regulatory pathways for
therapeutic targeting. Am J Clin Exp Urol. 2:92–101.
2014.PubMed/NCBI
|
|
5
|
Clucas J and Valderrama F: ERM proteins in
cancer progression. J Cell Sci. 128:12532015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Xu J, Lamouille S and Derynck R:
TGF-β-induced epithelial to mesenchymal transition. Cell Res.
19:156–172. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
McConkey DJ, Choi W, Marquis L, Martin F,
Williams MB, Shah J, Svatek R, Das A, Adam L, Kamat A, et al: Role
of epithelial-to-mesenchymal transition (EMT) in drug sensitivity
and metastasis in bladder cancer. Cancer Metastasis Rev.
28:335–344. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Min C, Eddy SF, Sherr DH and Sonenshein
GE: NF-kappaB and epithelial to mesenchymal transition of cancer. J
Cell Biochem. 104:733–744. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Napetschnig J and Wu H: Molecular basis of
NF-κB signaling. Annu Rev Biophys. 42:443–468. 2013. View Article : Google Scholar :
|
|
10
|
Kim SW, Schifano M, Oleksyn D, Jordan CT,
Ryan D, Insel R, Zhao J and Chen L: Protein kinase C-associated
kinase regulates NF-κB activation through inducing IKK activation.
Int J Oncol. 45:1707–1714. 2014.PubMed/NCBI
|
|
11
|
Courtois G and Israël A: IKK regulation
and human genetics. Curr Top Microbiol Immunol. 349:73–95.
2011.
|
|
12
|
Yang J, Amiri KI, Burke JR, Schmid JA and
Richmond A: BMS-345541 targets inhibitor of kappaB kinase and
induces apoptosis in melanoma: Involvement of nuclear factor kappaB
and mitochondria pathways. Clin Cancer Res. 12:950–960. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Nguyen DP, Li J, Yadav SS and Tewari AK:
Recent insights into NF-κB signalling pathways and the link between
inflammation and prostate cancer. BJU Int. 114:168–176. 2014.
View Article : Google Scholar
|
|
14
|
Burke JR, Pattoli MA, Gregor KR, Brassil
PJ, MacMaster JF, McIntyre KW, Yang X, Iotzova VS, Clarke W, Strnad
J, et al: BMS-345541 is a highly selective inhibitor of I kappa B
kinase that binds at an allosteric site of the enzyme and blocks
NF-kappa B-dependent transcription in mice. J Biol Chem.
278:1450–1456. 2003. View Article : Google Scholar
|
|
15
|
Gasparian AV, Yao YJ, Kowalczyk D, Lyakh
LA, Karseladze A, Slaga TJ and Budunova IV: The role of IKK in
constitutive activation of NF-kappaB transcription factor in
prostate carcinoma cells. J Cell Sci. 115:141–151. 2002.PubMed/NCBI
|
|
16
|
Dyson HJ and Komives EA: Role of disorder
in IκB-NFκB interaction. IUBMB Life. 64:499–505. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Luo Y, Cui X, Zhao J, Han Y, Li M, Lin Y,
Jiang Y and Lan L: Cells susceptible to epithelial-mesenchymal
transition are enriched in stem-like side population cells from
prostate cancer. Oncol Rep. 31:874–884. 2014.
|
|
18
|
Behnsawy HM, Miyake H, Harada K and
Fujisawa M: Expression patterns of epithelial-mesenchymal
transition markers in localized prostate cancer: Significance in
clinicopathological outcomes following radical prostatectomy. BJU
Int. 111:30–37. 2013. View Article : Google Scholar
|
|
19
|
Thiery JP, Acloque H, Huang RYJ and Nieto
MA: Epithelial- mesenchymal transitions in development and disease.
Cell. 139:871–890. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Chen Z, Zhang D, Yue F, Zheng M, Kovacevic
Z and Richardson DR: The iron chelators Dp44mT and DFO inhibit
TGF-β-induced epithelial-mesenchymal transition via upregulation of
N-Myc downstream-regulated gene 1 (NDRG1). J Biol Chem.
287:17016–17028. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Jain G, Voogdt C, Tobias A, Spindler KD,
Möller P, Cronauer MV and Marienfeld RB: IκB kinases modulate the
activity of the androgen receptor in prostate carcinoma cell lines.
Neoplasia. 14:178–189. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Bradford JW and Baldwin AS: IKK/nuclear
factor-kappaB and oncogenesis: Roles in tumor-initiating cells and
in the tumor microenvironment. Adv Cancer Res. 121:125–145. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Tada Y, Kokabu S, Sugiyama G, Nakatomi C,
Aoki K, Fukushima H, Osawa K, Sugamori Y, Ohya K, Okamoto M, et al:
The novel IκB kinase β inhibitor IMD-0560 prevents bone invasion by
oral squamous cell carcinoma. Oncotarget. 5:12317–12330. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Shi J, Chen J, Serradji N, Xu X, Zhou H,
Ma Y, Sun Z, Jiang P, Du Y, Yang J, et al: PMS1077 sensitizes TNF-α
induced apoptosis in human prostate cancer cells by blocking NF-κB
signaling pathway. PLoS One. 8:e611322013. View Article : Google Scholar
|
|
25
|
Fang BA, Kovačević Ž, Park KC, Kalinowski
DS, Jansson PJ, Lane DJR, Sahni S and Richardson DR: Molecular
functions of the iron-regulated metastasis suppressor, NDRG1, and
its potential as a molecular target for cancer therapy. Biochim
Biophys Acta. 1845:1–19. 2014.
|
|
26
|
Sánchez-Tilló E, Liu Y, de Barrios O,
Siles L, Fanlo L, Cuatrecasas M, Darling DS, Dean DC, Castells A
and Postigo A: EMT-activating transcription factors in cancer:
Beyond EMT and tumor invasiveness. Cell Mol Life Sci. 69:3429–3456.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Lee JC, Chung LC, Chen YJ, Feng TH and
Juang HH: N-myc downstream-regulated gene 1 downregulates cell
proliferation, invasiveness, and tumorigenesis in human oral
squamous cell carcinoma. Cancer Lett. 355:242–252. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
McCall P, Bennett L, Ahmad I, Mackenzie
LM, Forbes IWG, Leung HY, Sansom OJ, Orange C, Seywright M,
Underwood MA, et al: NFκB signalling is upregulated in a subset of
castrate- resistant prostate cancer patients and correlates with
disease progression. Br J Cancer. 107:1554–1563. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kovacevic Z and Richardson DR: The
metastasis suppressor, Ndrg-1: A new ally in the fight against
cancer. Carcinogenesis. 27:2355–2366. 2006. View Article : Google Scholar : PubMed/NCBI
|
